PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26069510-10	2013	Direct covalent coupling of antibodies to nanoparticles using glutaraldehyde as a cross-linker is an appropriate method to achieve cell type-specific drug carrier systems based on PLGA-PEG nanoparticles and the anti-EGFR-decorated PLGA-PEG nanoparticles have potentials to be applied for targeted chemotherapy against EGFR positive cancers.	Glutaral	62-76	epidermal growth factor receptor	Homo sapiens	216-220	
26069510-10	2013	Direct covalent coupling of antibodies to nanoparticles using glutaraldehyde as a cross-linker is an appropriate method to achieve cell type-specific drug carrier systems based on PLGA-PEG nanoparticles and the anti-EGFR-decorated PLGA-PEG nanoparticles have potentials to be applied for targeted chemotherapy against EGFR positive cancers.	Glutaral	62-76	epidermal growth factor receptor	Homo sapiens	318-322	
1316148-1	1992	Dimerization of epidermal growth factor receptor dissolved in a solution of nonionic detergent was followed with a resolution of 1 min by quantitative cross-linking with glutaraldehyde.	Glutaral	170-184	epidermal growth factor receptor	Homo sapiens	16-48	
21485840-2	2011	It was observed that direct covalent coupling of antibodies to glutaraldehyde activated nanoparticles is an appropriate method to achieve cell-type specific drug carrier systems based on polymeric nanoparticles that have potential to be applied for targeted chemotherapy in EGFR positive cancer.	Glutaral	63-77	epidermal growth factor receptor	Homo sapiens	274-278	
9335547-3	1997	Dimerization of EGF receptor was monitored by immunoblotting the protein after it had been cross-linked with glutaraldehyde.	Glutaral	109-123	epidermal growth factor receptor	Homo sapiens	16-28